A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges

References

• Murphy TF. Vaccine development for Moraxella catarrhalis: rationale, approaches and challenges. Expert Rev Vaccines. 2009;8:655-8. doi:10.1586/erv.09.28. PMID:19485745
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Subcommittee on Management of Acute Otitis M . Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-65. doi:10.1542/peds.113.5.1451. PMID:15121972
   PubMed Web of Science ®Google Scholar
• Kaplan B , Wandstrat TL , Cunningham JR . Overall cost in the treatment of otitis media. Pediatr Infect Dis J. 1997;16:S9-11. doi:10.1097/00006454-199702001-00003. PMID:9041621
   PubMed Web of Science ®Google Scholar
• Stool SE , Field MJ . The impact of otitis media. Pediatr Infect Dis J. 1989;8:S11-4. doi:10.1097/00006454-198901001-00006. PMID:2494641
   PubMed Web of Science ®Google Scholar
• Murphy TF , Brauer AL , Grant BJ , Sethi S . Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med. 2005;172:195-9. doi:10.1164/rccm.200412-1747OC. PMID:15805178
   PubMed Web of Science ®Google Scholar
• Mustafa G , Al Aidaroos AY , Al Abaidani IS , Meszaros K , Gopala K , Ceyhan M , Al-Tannir M , DeAntonio R , Bawikar S , Schmidt JE . Incidence and economic burden of acute otitis media in children aged up to 5 years in three Middle Eastern countries and Pakistan: A multinational, retrospective, observational study. J Epidemiol Glob Health. 2017;7(2):123-130. doi:10.1016/j.jegh.2016.12.004. PMID:28188119
   PubMed Web of Science ®Google Scholar
• Rovers MM . The burden of otitis media. Vaccine. 2008;26 Suppl 7:G2-4. doi:10.1016/j.vaccine.2008.11.005
   PubMed Web of Science ®Google Scholar
• Foo J , Landis SH , Maskell J , Oh YM , van der Molen T , Han MK , Mannino DM , Ichinose M , Punekar Y . Continuing to Confront COPD International Patient survey: economic impact of COPD in 12 countries. PLoS One. 2016;11:e0152618. doi:10.1371/journal.pone.0152618. PMID:27092775
   PubMed Web of Science ®Google Scholar
• Enright MC , McKenzie H . Moraxella (Branhamella) catarrhalis-clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol. 1997;46:360-71. doi:10.1099/00222615-46-5-360. PMID:9152030
   PubMed Web of Science ®Google Scholar
• Verduin CM , Hol C , Fleer A , van Dijk H , van Belkum A . Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev. 2002;15:125-44. doi:10.1128/CMR.15.1.125-144.2002. PMID:11781271
   PubMed Web of Science ®Google Scholar
• de Vries SP , Bootsma HJ , Hays JP , Hermans PW . Molecular aspects of Moraxella catarrhalis pathogenesis. Microbiol Mol Biol Rev. 2009;73:389. doi:10.1128/MMBR.00007-09. PMID:19721084
   PubMed Web of Science ®Google Scholar
• Lafontaine ER , Cope LD , Aebi C , Latimer JL , McCracken GH, Jr , Hansen EJ . The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro . J Bacteriol. 2000;182:1364-73. doi:10.1128/JB.182.5.1364-1373.2000. PMID:10671460
   PubMed Web of Science ®Google Scholar
• Forsgren A , Brant M , Mollenkvist A , Muyombwe A , Janson H , Woin N ,   Riesbeck K . Isolation and characterization of a novel IgD-binding protein from Moraxella catarrhalis . J Immunol. 2001;167:2112-20. doi:10.4049/jimmunol.167.4.2112. PMID:11489995
   PubMed Web of Science ®Google Scholar
• Luke NR , Jurcisek JA , Bakaletz LO , Campagnari AA . Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect Immun. 2007;75:5559-64. doi:10.1128/IAI.00946-07. PMID:17908808
   PubMed Web of Science ®Google Scholar
• Tan TT , Nordstrom T , Forsgren A , Riesbeck K . The respiratory pathogen Moraxella catarrhalis adheres to epithelial cells by interacting with fibronectin through ubiquitous surface proteins A1 and A2. J Infect Dis. 2005;192:1029-38. doi:10.1086/432759. PMID:16107956
   PubMed Web of Science ®Google Scholar
• McMichael JC , Fiske MJ , Fredenburg RA , Chakravarti DN , VanDerMeid KR , Barniak V , Caplan J , Bortell E , Baker S , Arumugham R , et al. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect Immun. 1998;66:4374-81. PMID:9712790
   PubMed Web of Science ®Google Scholar
• Nordstrom T , Blom AM , Forsgren A , Riesbeck K . The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol. 2004;173:4598-606. doi:10.4049/jimmunol.173.7.4598. PMID:15383594
   PubMed Web of Science ®Google Scholar
• Nordstrom T , Blom AM , Tan TT , Forsgren A , Riesbeck K . Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity. J Immunol. 2005;175:3628-36. doi:10.4049/jimmunol.175.6.3628. PMID:16148107
   PubMed Web of Science ®Google Scholar
• Attia AS , Ram S , Rice PA , Hansen EJ . Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun. 2006;74:1597-611. doi:10.1128/IAI.74.3.1597-1611.2006. PMID:16495531
   PubMed Web of Science ®Google Scholar
• Singh B , Al-Jubair T , Voraganti C , Andersson T , Mukherjee O , Su YC , Zipfel P , Riesbeck K . Moraxella catarrhalis binds plasminogen to evade host innate immunity. Infect Immun. 2015;83:3458-69. doi:10.1128/IAI.00310-15. PMID:26099590
   PubMed Web of Science ®Google Scholar
• Schwechheimer C , Kuehn MJ . Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol. 2015;13:605-19. doi:10.1038/nrmicro3525. PMID:26373371
   PubMed Web of Science ®Google Scholar
• Yoon H . Bacterial outer membrane vesicles as a delivery system for virulence regulation. J Microbiol Biotechnol. 2016;26:1343-7. doi:10.4014/jmb.1604.04080. PMID:27221110
   PubMed Web of Science ®Google Scholar
• Su YC , Singh B , Riesbeck K . Moraxella catarrhalis: from interactions with the host immune system to vaccine development. Future Microbiol. 2012;7:1073-100. doi:10.2217/fmb.12.80. PMID:22953708
   PubMed Web of Science ®Google Scholar
• Jendholm J , Samuelsson M , Cardell LO , Forsgren A , Riesbeck K . Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production. J Leukoc Biol. 2008;83:1370-8. doi:10.1189/jlb.1107788. PMID:18372337
   PubMed Web of Science ®Google Scholar
• Gjorloff Wingren A , Hadzic R , Forsgren A , Riesbeck K . The novel IgD binding protein from Moraxella catarrhalis induces human B lymphocyte activation and Ig secretion in the presence of Th2 cytokines. J Immunol. 2002;168:5582-8. doi:10.4049/jimmunol.168.11.5582. PMID:12023354
   PubMed Web of Science ®Google Scholar
• World Health Organization . Global action plan on antimicrobial resistance. Geneva (Switzerland): WHO Press; 2015
   Google Scholar
• Wallace RJ, Jr , Steingrube VA , Nash DR , Hollis DG , Flanagan C , Brown BA , Labidi A , Weaver RE . BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata . Antimicrob Agents Chemother. 1989;33:1845-54. doi:10.1128/AAC.33.11.1845. PMID:2514622
   PubMed Web of Science ®Google Scholar
• Wallace RJ, Jr , Nash DR , Steingrube VA . Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis . Am J Med. 1990;88:46S-50S. doi:10.1016/0002-9343(90)90262-C. PMID:2111092
   PubMed Web of Science ®Google Scholar
• Brook I . The role of beta-lactamase-producing-bacteria in mixed infections. BMC Infect Dis. 2009;9:202. doi:10.1186/1471-2334-9-202. PMID:20003454
   PubMed Web of Science ®Google Scholar
• Perez AC , Pang B , King LB , Tan L , Murrah KA , Reimche JL , Wren JT , Richardson SH , Ghandi U , Swords WE . Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo . Pathogens Dis. 2014;70:280-8. doi:10.1111/2049-632X.12129. PMID:24391058
   PubMed Web of Science ®Google Scholar
• Armbruster CE , Hong W , Pang B , Weimer KE , Juneau RA , Turner J , Swords WE . Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. mBio. 2010;1:e00102-10. doi:10.1128/mBio.00102-10. PMID:20802829
   PubMed Web of Science ®Google Scholar
• Eliasson I , Kamme C , Vang M , Waley SG . Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens . Eur J Clin Microbiol Infect Dis. 1992;11:313-21. doi:10.1007/BF01962070. PMID:1396750
   PubMed Web of Science ®Google Scholar
• Bootsma HJ , Aerts PC , Posthuma G , Harmsen T , Verhoef J , van Dijk H , Mooi FR . Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin? J Bacteriol. 1999;181:5090-3. PMID:10438784
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L , Hu FZ , Gieseke A , Nistico L , Nguyen D , Hayes J , Forbes M , Greenberg DP , Dice B , Burrows A , et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296:202-11. doi:10.1001/jama.296.2.202. PMID:16835426
   PubMed Web of Science ®Google Scholar
• Torretta S , Marchisio P , Drago L , Baggi E , De Vecchi E , Garavello W , et al. Nasopharyngeal biofilm-producing otopathogens in children with nonsevere recurrent acute otitis media. Otolaryngol Head Neck Surg. 2012;146:991-6. doi:10.1177/0194599812438169. PMID:22357644
   PubMed Web of Science ®Google Scholar
• Bakaletz LO . Bacterial biofilms in the upper airway - evidence for role in pathology and implications for treatment of otitis media. Paediatr Respir Rev. 2012;13:154-9. doi:10.1016/j.prrv.2012.03.001. PMID:22726871
   PubMed Web of Science ®Google Scholar
• Post JC , Hiller NL , Nistico L , Stoodley P , Ehrlich GD . The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg. 2007;15:347-51. doi:10.1097/MOO.0b013e3282b97327. PMID:17823552
   PubMedGoogle Scholar
• Slinger R , Chan F , Ferris W , Yeung SW , St Denis M , Gaboury I , Aaron SD . Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms. Diagn Microbiol Infect Dis. 2006;56:247-53. doi:10.1016/j.diagmicrobio.2006.04.012. PMID:16769194
   PubMed Web of Science ®Google Scholar
• Teele DW , Klein JO , Rosner B . Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83-94. doi:10.1093/infdis/160.1.83. PMID:2732519
   PubMed Web of Science ®Google Scholar
• Tawfik KO , Ishman SL , Altaye M , Meinzen-Derr J , Choo DI . Pediatric Acute Otitis Media in the Era of Pneumococcal Vaccination. Otolaryngol Head Neck Surg. 2017;156:938-45. doi:10.1177/0194599817699599. PMID:28349737
   PubMed Web of Science ®Google Scholar
• Paradise JL , Rockette HE , Colborn DK , Bernard BS , Smith CG , Kurs-Lasky M , Janosky JE . Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99:318-33. doi:10.1542/peds.99.3.318. PMID:9041282
   PubMed Web of Science ®Google Scholar
• Usonis V , Jackowska T , Petraitiene S , Sapala A , Neculau A , Stryjewska I , Devadiga R , Tafalla M , Holl K . Incidence of acute otitis media in children below 6 years of age seen in medical practices in five East European countries. BMC Pediatr. 2016;16:108. doi:10.1186/s12887-016-0638-2. PMID:27457584
   PubMed Web of Science ®Google Scholar
• Barber C , Ille S , Vergison A , Coates H . Acute otitis media in young children - what do parents say? Int J Pediatr Otorhinolaryngol. 2014;78:300-6. doi:10.1016/j.ijporl.2013.11.030. PMID:24374143
   PubMed Web of Science ®Google Scholar
• Lambert E , Roy S . Otitis media and ear tubes. Pediatr Clin North Am. 2013;60:809-26. doi:10.1016/j.pcl.2013.04.014. PMID:23905821
   PubMed Web of Science ®Google Scholar
• McDonald S , Langton Hewer CD , Nunez DA . Grommets (ventilation tubes) for recurrent acute otitis media in children. Cochrane Database Syst Rev. 2008;(4):CD004741. PMID:18843668
   PubMed Web of Science ®Google Scholar
• Lous J , Burton MJ , Felding JU , Ovesen T , Rovers MM , Williamson I . Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2005;(1):CD001801. PMID:15674886
   PubMed Web of Science ®Google Scholar
• Marchisio P , Esposito S , Picca M , Baggi E , Terranova L , Orenti A , Biganzoli E , Principi N . Prospective evaluation of the aetiology of acute otitis media with spontaneous tympanic membrane perforation. Clin Microbiol Infect. 2017;23(7):486. doi:10.1016/j.cmi.2017.01.010. PMID:28110050
   PubMed Web of Science ®Google Scholar
• Sillanpaa S , Kramna L , Oikarinen S , Sipila M , Rautiainen M , Aittoniemi J , Laranne J , Hyöty H , Cinek O . Next-generation sequencing combined with specific PCR assays to determine the bacterial 16S rRNA gene profiles of middle ear fluid collected from children with acute otitis media. mSphere. 2017;2:e00006-17. doi:10.1128/mSphere.00006-17. PMID:28357413
   PubMed Web of Science ®Google Scholar
• Sillanpaa S , Oikarinen S , Sipila M , Kramna L , Rautiainen M , Huhtala H , Aittoniemi J , Laranne J , Hyöty H , Cinek O . Moraxella catarrhalis might be more common than expected in acute otitis media in young finnish children. J Clin Microbiol. 2016;54:2373-9. doi:10.1128/JCM.01146-16. PMID:27413187
   PubMed Web of Science ®Google Scholar
• Ngo CC , Massa HM , Thornton RB , Cripps AW . Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: a systematic review. PLoS One. 2016;11:e0150949. doi:10.1371/journal.pone.0150949. PMID:26953891
   PubMed Web of Science ®Google Scholar
• Kaur R , Czup K , Casey JR , Pichichero ME . Correlation of nasopharyngeal cultures prior to and at onset of acute otitis media with middle ear fluid cultures. BMC Infect Dis. 2014;14:640. doi:10.1186/s12879-014-0640-y. PMID:25475135
   PubMed Web of Science ®Google Scholar
• Broides A , Dagan R , Greenberg D , Givon-Lavi N , Leibovitz E . Acute otitis media caused by Moraxella catarrhalis: epidemiologic and clinical characteristics. Clin Infect Dis. 2009;49:1641-7. doi:10.1086/647933. PMID:19886799
   PubMed Web of Science ®Google Scholar
• Ruohola A , Pettigrew MM , Lindholm L , Jalava J , Raisanen KS , Vainionpaa R , Waris M , Tähtinen PA , Laine MK , Lahti E . Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media. J Infect. 2013;66:247-54. doi:10.1016/j.jinf.2012.12.002. PMID:23266462
   PubMed Web of Science ®Google Scholar
• Pettigrew MM , Gent JF , Pyles RB , Miller AL , Nokso-Koivisto J , Chonmaitree T . Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol. 2011;49:3750-5. doi:10.1128/JCM.01186-11. PMID:21900518
   PubMed Web of Science ®Google Scholar
• Wiertsema SP , Chidlow GR , Kirkham LA , Corscadden KJ , Mowe EN , Vijayasekaran S , Coates HL , Harnett GB , Richmond PC . High detection rates of nucleic acids of a wide range of respiratory viruses in the nasopharynx and the middle ear of children with a history of recurrent acute otitis media. J Med Virol. 2011;83:2008-17. doi:10.1002/jmv.22221. PMID:21915878
   PubMed Web of Science ®Google Scholar
• Chonmaitree T , Trujillo R , Jennings K , Alvarez-Fernandez P , Patel JA , Loeffelholz MJ , Nokso-Koivisto J , Matalon R , Pyles RB , Miller AL , et al. Acute Otitis media and other complications of viral respiratory infection. Pediatrics. 2016;137:e2015355. doi:10.1542/peds.2015-3555
   Web of Science ®Google Scholar
• Uitti JM , Tahtinen PA , Laine MK , Huovinen P , Ruuskanen O , Ruohola A . Role of Nasopharyngeal bacteria and respiratory viruses in acute symptoms of young children. Pediatr Infect Dis J. 2015;34:1056-62. doi:10.1097/INF.0000000000000800. PMID:26164848
   PubMed Web of Science ®Google Scholar
• Kim KH , Hong JY , Lee H , Kwak GY , Nam CH , Lee SY , Oh E , Yu J , Nahm MH , Kang JH . Nasopharyngeal pneumococcal carriage of children attending day care centers in Korea: comparison between children immunized with 7-valent pneumococcal conjugate vaccine and non-immunized. J Korean Med Sci. 2011;26:184-90. doi:10.3346/jkms.2011.26.2.184. PMID:21286007
   PubMed Web of Science ®Google Scholar
• Rodrigues F , Nunes S , Sa-Leao R , Goncalves G , Lemos L , de Lencastre H . Streptococcus pneumoniae nasopharyngeal carriage in children attending day-care centers in the central region of Portugal, in the era of 7-valent pneumococcal conjugate vaccine. Microb Drug Resist. 2009;15:269-77. doi:10.1089/mdr.2009.0043. PMID:19857133
   PubMed Web of Science ®Google Scholar
• Bryant KA , Block SL , Baker SA , Gruber WC , Scott DA , Group PCVIS . Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics. 2010;125:866-75. doi:10.1542/peds.2009-1405. PMID:20435707
   PubMed Web of Science ®Google Scholar
• Soysal A , Karabag-Yilmaz E , Kepenekli E , Karaaslan A , Cagan E , Atici S , Atınkanat-Gelmez G , Boran P , Merdan S , Hasdemir U , et al. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey. Vaccine. 2016;34:3894-900. doi:10.1016/j.vaccine.2016.05.043. PMID:27269059
   PubMed Web of Science ®Google Scholar
• Holder RC , Kirse DJ , Evans AK , Whigham AS , Peters TR , Poehling KA , Swords WE , Reid SD . Otopathogens detected in middle ear fluid obtained during tympanostomy tube insertion: contrasting purulent and non-purulent effusions. PLoS One. 2015;10:e0128606. doi:10.1371/journal.pone.0128606. PMID:26039250
   PubMed Web of Science ®Google Scholar
• Polachek A , Greenberg D , Lavi-Givon N , Broides A , Leiberman A , Dagan R , Leibovitz E . Relationship among peripheral leukocyte counts, etiologic agents and clinical manifestations in acute otitis media. Pediatr Infect Dis J. 2004;23:406-13. doi:10.1097/01.inf.0000122603.78338.bd. PMID:15131462
   PubMed Web of Science ®Google Scholar
• Schaar V , Nordström T , Mörgelin M . Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrobial Agents Chemotherapy. 2011;55(8):3845-53. doi:10.1128/AAC.01772-10. PMID:21576428
   PubMed Web of Science ®Google Scholar
• Kaieda S , Yano H , Okitsu N , Hosaka Y , Okamoto R , Inoue M , Takahashi H . In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora. Int J Pediatr Otorhinolaryngol. 2005;69:479-85. doi:10.1016/j.ijporl.2004.11.013. PMID:15763284
   PubMed Web of Science ®Google Scholar
• Hol C , Van Dijke EE , Verduin CM , Verhoef J , van Dijk H . Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. J Infect Dis. 1994;170:1613-6. doi:10.1093/infdis/170.6.1613. PMID:7996007
   PubMed Web of Science ®Google Scholar
• Stefani S , Pellegrino MB , Russo G , Nicoletti G . Direct and indirect pathogenicity of beta-lactamase-producing bacteria in respiratory tract infection in children. Role of cephalosporins resistant to enzymatic hydrolysis. Drugs. 1991;42 Suppl 4:14-8. doi:10.2165/00003495-199100424-00006. PMID:1725149
   PubMedGoogle Scholar
• Bafadhel M , Haldar K , Barker B , Patel H , Mistry V , Barer MR , Pavord ID , Brightling CE . Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function. Int J Chron Obstruct Pulmon Dis. 2015;10:1075-83. doi:10.2147/COPD.S80091. PMID:26089657
   PubMed Web of Science ®Google Scholar
• Ruckdeschel EA , Brauer AL , Johnson A , Murphy TF . Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis . Vaccine. 2009;27:7065-72. doi:10.1016/j.vaccine.2009.09.062. PMID:19786139
   PubMed Web of Science ®Google Scholar
• Smidt M , Battig P , Verhaegh SJ , Niebisch A , Hanner M , Selak S , Schüler W , Morfeldt E , Hellberg C , Nagy E , et al. Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model. PLoS One. 2013;8:e64422. doi:10.1371/journal.pone.0064422. PMID:23671716
   PubMed Web of Science ®Google Scholar
• Hu WG , Chen J , Collins FM , Gu XX . An aerosol challenge mouse model for Moraxella catarrhalis . Vaccine. 1999;18:799-804. doi:10.1016/S0264-410X(99)00335-7. PMID:10580192
   PubMed Web of Science ®Google Scholar
• Chen D , McMichael JC , VanDerMeid KR , Hahn D , Mininni T , Cowell J , Eldridge J . Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect Immun. 1996;64:1900-5. PMID:8675285
   PubMed Web of Science ®Google Scholar
• Shaffer TL , Balder R , Buskirk SW , Hogan RJ , Lafontaine ER . Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2. PLoS One. 2013;8:e67881. doi:10.1371/journal.pone.0067881. PMID:23844117
   PubMed Web of Science ®Google Scholar
• Sirakova T , Kolattukudy PE , Murwin D , Billy J , Leake E , Lim D , DeMaria T , Bakaletz L . Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect Immun. 1994;62:2002-20. PMID:7909539
   PubMed Web of Science ®Google Scholar
• Hong W , Mason K , Jurcisek J , Novotny L , Bakaletz LO , Swords WE . Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect Immun. 2007;75:958-65. doi:10.1128/IAI.01691-06. PMID:17130253
   PubMed Web of Science ®Google Scholar
• Murrah KA , Turner RL , Pang B , Perez AC , Reimche JL , King LB , Wren J , Gandhi U , Swords WE , Ornelles DA . Replication of type 5 adenovirus promotes middle ear infection by Streptococcus pneumoniae in the chinchilla model of otitis media. Pathog Dis. 2015;73:1-8. PMID:25251686
   PubMed Web of Science ®Google Scholar
• Brockson ME , Novotny LA , Jurcisek JA , McGillivary G . Respiratory syncytial virus promotes Moraxella catarrhalis-induced ascending experimental otitis media. PloS One. 2012;7(6):e40088. doi:10.1371/journal.pone.0040088. PMID:22768228
   PubMed Web of Science ®Google Scholar
• Murrah KA , Pang B , Richardson S , Perez A , Reimche J , King L , Wren J , Swords WE . Nonencapsulated Streptococcus pneumoniae causes otitis media during single-species infection and during polymicrobial infection with nontypeable Haemophilus influenzae . Pathog Dis. 2015;73(5):ftu011. doi:10.1093/femspd/ftu011
   PubMed Web of Science ®Google Scholar
• Liu DF , McMichael JC , Baker SM . Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model. Infect Immun. 2007;75:2818-25. doi:10.1128/IAI.00074-07. PMID:17403868
   PubMed Web of Science ®Google Scholar
• D'Elios MM , Benagiano M , Della Bella C , Amedei A . T-cell response to bacterial agents. J Infect Dev Ctries. 2011;5:640-5. doi:10.3855/jidc.2019. PMID:21918304
   PubMed Web of Science ®Google Scholar
• Zhang Z , Clarke TB , Weiser JN . Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009;119:1899-909. PMID:19509469
   PubMed Web of Science ®Google Scholar
• Noda K , Kodama S , Umemoto S , Nomi N , Hirano T , Suzuki M . Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide. Microbiol Immunol. 2011;55:574-81. doi:10.1111/j.1348-0421.2011.00352.x. PMID:21605159
   PubMed Web of Science ®Google Scholar
• Dekker CL , Gordon L , Klein J . Dose optimization strategies for vaccines: the role of adjuvants and new technologies. NVAC Subcommittee on Vaccine Development and Supply. Washingon, DC: HHS; 2008
   Google Scholar
• Beyer WE , Palache AM , de Jong JC , Osterhaus AD . Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine. 2002;20:1340-53. doi:10.1016/S0264-410X(01)00471-6. PMID:11818152
   PubMed Web of Science ®Google Scholar
• Aebi C , Cope LD , Latimer JL , Thomas SE , Slaughter CA , McCracken GH, Jr , Hansen EJ . Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis . Infect Immun. 1998;66:540-8. PMID:9453607
   PubMed Web of Science ®Google Scholar
• Liu DF , Xie X , Mastri MG , Fortuna-Nevin M , Colocillo C , Fletcher L , Dilts DA , McMichael JC , Baker SM . Polymorphism of the major surface epitope of the CopB outer membrane protein of Moraxella catarrhalis . FEMS Immunol Med Microbiol. 2006;47:343-50. doi:10.1111/j.1574-695X.2006.00093.x. PMID:16872370
   PubMedGoogle Scholar
• Meier PS , Freiburghaus S , Martin A , Heiniger N , Troller R , Aebi C . Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children. Pediatr Infect Dis J. 2003;22:256-62. doi:10.1097/01.inf.0000054827.86683.bd. PMID:12634588
   PubMed Web of Science ®Google Scholar
• Stutzmann Meier P , Heiniger N , Troller R , Aebi C . Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults. Infect Immun. 2003;71:6793-8. doi:10.1128/IAI.71.12.6793-6798.2003. PMID:14638765
   PubMed Web of Science ®Google Scholar
• Murphy TF , Brauer AL , Aebi C , Sethi S . Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect Immun. 2005;73:8161-6. doi:10.1128/IAI.73.12.8161-8166.2005. PMID:16299311
   PubMed Web of Science ®Google Scholar
• Murphy TF , Kirkham C , Johnson A , Brauer AL , Koszelak-Rosenblum M , Malkowski MG . Sulfate-binding protein, CysP, is a candidate vaccine antigen of Moraxella catarrhalis . Vaccine. 2016;34:3855-61. doi:10.1016/j.vaccine.2016.05.045. PMID:27265455
   PubMed Web of Science ®Google Scholar
• Hu WG , Chen J , Battey JF , Gu XX . Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins. Infect Immun. 2000;68:4980-5. doi:10.1128/IAI.68.9.4980-4985.2000. PMID:10948114
   PubMed Web of Science ®Google Scholar
• Bakri F , Brauer AL , Sethi S , Murphy TF . Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease. J Infect Dis. 2002;185:632-40. doi:10.1086/339174. PMID:11865420
   PubMed Web of Science ®Google Scholar
• Gu XX , Chen J , Barenkamp SJ , Robbins JB , Tsai CM , Lim DJ , Battey J . Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis . Infect Immun. 1998;66:1891-7. PMID:9573066
   PubMed Web of Science ®Google Scholar
• Jiao X , Hirano T , Hou Y , Gu XX . Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine. Infect Immun. 2002;70(11):5982-9. doi:10.1128/IAI.70.11.5982-5989.2002. PMID:12379673
   PubMed Web of Science ®Google Scholar
• Yu S , Gu XX . Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis . Infect Immun. 2005;73:2790-6. doi:10.1128/IAI.73.5.2790-2796.2005. PMID:15845482
   PubMed Web of Science ®Google Scholar
• Yu S , Gu XX . Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis . Infect Immun. 2007;75:2974-80. doi:10.1128/IAI.01915-06. PMID:17371852
   PubMed Web of Science ®Google Scholar
• Yu S , Xie H , Datta A , Naidu N , Gu XX . Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination. Infect Immun. 2008;76:4251-8. doi:10.1128/IAI.01570-07. PMID:18559429
   PubMed Web of Science ®Google Scholar
• Hu WG , Chen J , McMichael JC , Gu XX . Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis . Infect Immun. 2001;69:1358-63. doi:10.1128/IAI.69.3.1358-1363.2001. PMID:11179299
   PubMed Web of Science ®Google Scholar
• Schwingel JM , Edwards KJ , Cox AD , Masoud H , Richards JC , St Michael F , Tekwe CD , Sethi S , Murphy TF , Campagnari AA . Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies. Infect Immun. 2009;77:4548-58. doi:10.1128/IAI.00294-09. PMID:19651870
   PubMed Web of Science ®Google Scholar
• Gergova RT , Iankov ID , Haralambieva IH , Mitov IG . Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp. Curr Microbiol. 2007;54:85-90. doi:10.1007/s00284-005-0463-6. PMID:17211546
   PubMed Web of Science ®Google Scholar
• Hu WG , Berry J , Chen J , Gu XX . Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates. FEMS Immunol Med Microbiol. 2004;41:109-15. doi:10.1016/j.femsim.2004.02.001
   PubMedGoogle Scholar
• Forsgren A , Brant M , Riesbeck K . Immunization with the truncated adhesin Moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance. J Infect Dis. 2004;190:352-5. doi:10.1086/422155
   PubMed Web of Science ®Google Scholar
• Riesbeck K , Tan TT , Forsgren A . MID and UspA1/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development. Acta Biochim Pol. 2006;53:445-56. PMID:16964325
   PubMed Web of Science ®Google Scholar
• Bullard B , Lipski SL , Lafontaine ER . Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells. Infect Immun. 2005;73:5127-36. doi:10.1128/IAI.73.8.5127-5136.2005. PMID:16041029
   PubMed Web of Science ®Google Scholar
• LaFontaine ER , Snipes LE , Bullard B , Brauer AL , Sethi S , Murphy TF . Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis . Clin Vaccine Immunol. 2009;16:653-9. doi:10.1128/CVI.00460-08. PMID:19321697
   PubMed Web of Science ®Google Scholar
• Verhaegh SJ , de Vogel CP , Riesbeck K , Lafontaine ER , Murphy TF , Verbrugh HA , Jaddoe VW , Hofman A , Moll HA , van Belkum A , et al. Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants. Vaccine. 2011;29:5603-10. doi:10.1016/j.vaccine.2011.06.019. PMID:21704103
   PubMed Web of Science ®Google Scholar
• Tan TT , Christensen JJ , Dziegiel MH , Forsgren A , Riesbeck K . Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2. Infect Immun. 2006;74:6377-86. doi:10.1128/IAI.00702-06. PMID:16966403
   PubMed Web of Science ®Google Scholar
• Ren D , Almudevar AL , Murphy TF , Lafontaine ER , Campagnari AA , Luke-Marshall N , Casey JR , Pichichero ME . Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 2015;33:5809-14. doi:10.1016/j.vaccine.2015.09.023. PMID:26392013
   PubMed Web of Science ®Google Scholar
• Murphy TF , Brauer AL , Aebi C , Sethi S . Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect Immun. 2005;73:3471-8. doi:10.1128/IAI.73.6.3471-3478.2005. PMID:15908376
   PubMed Web of Science ®Google Scholar
• Yassin GM , Amin MA , Attia AS . Immunoinformatics Identifies a Lactoferrin binding protein a peptide as a promising vaccine with a global protective prospective against Moraxella catarrhalis . J Infect Dis. 2016;213:1938-45. doi:10.1093/infdis/jiw062. PMID:26908723
   PubMed Web of Science ®Google Scholar
• Easton DM , Smith A , Gallego SG , Foxwell AR , Cripps AW , Kyd JM . Characterization of a novel porin protein from Moraxella catarrhalis and identification of an immunodominant surface loop. J Bacteriol. 2005;187:6528-35. doi:10.1128/JB.187.18.6528-6535.2005. PMID:16159786
   PubMed Web of Science ®Google Scholar
• Easton DM , Cripps AW , Foxwell AR , Kyd JM . Mucosal immunization with the Moraxella Catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis. Front Immunol. 2011;2:13. doi:10.3389/fimmu.2011.00013. PMID:22566804
   PubMed Web of Science ®Google Scholar
• Easton DM , Maier E , Benz R , Foxwell AR , Cripps AW , Kyd JM . Moraxella catarrhalis M35 is a general porin that is important for growth under nutrient-limiting conditions and in the nasopharynges of mice. J Bacteriol. 2008;190:7994-8002. doi:10.1128/JB.01039-08. PMID:18931134
   PubMed Web of Science ®Google Scholar
• Lipski SL , Akimana C , Timpe JM , Wooten RM , Lafontaine ER . The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain. Infect Immun. 2007;75:314-24. doi:10.1128/IAI.01330-06. PMID:17088358
   PubMed Web of Science ®Google Scholar
• Timpe JM , Holm MM , Vanlerberg SL , Basrur V , Lafontaine ER . Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities. Infect Immun. 2003;71:4341-50. doi:10.1128/IAI.71.8.4341-4350.2003. PMID:12874311
   PubMed Web of Science ®Google Scholar
• Plamondon P , Luke NR , Campagnari AA . Identification of a novel two-partner secretion locus in Moraxella catarrhalis . Infect Immun. 2007;75:2929-36. doi:10.1128/IAI.00396-07. PMID:17420235
   PubMed Web of Science ®Google Scholar
• Ruckdeschel EA , Kirkham C , Lesse AJ , Hu Z , Murphy TF . Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect Immun. 2008;76:1599-607. doi:10.1128/IAI.01253-07. PMID:18227159
   PubMed Web of Science ®Google Scholar
• Bernhard S , Fleury C , Su YC , Zipfel PF , Koske I , Nordstrom T , Riesbeck K . Outer membrane protein OlpA contributes to Moraxella catarrhalis serum resistance via interaction with factor H and the alternative pathway. J Infect Dis. 2014;210:1306-10. doi:10.1093/infdis/jiu241. PMID:24771863
   PubMed Web of Science ®Google Scholar
• Brooks MJ , Laurence CA , Hansen EJ , Gray-Owen SD . Characterization of the Moraxella catarrhalis opa-like protein, OlpA, reveals a phylogenetically conserved family of outer membrane proteins. J Bacteriol. 2007;189:76-82. doi:10.1128/JB.00788-06. PMID:17041038
   PubMed Web of Science ®Google Scholar
• Murphy TF , Kirkham C , Lesse AJ . The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis . Mol Microbiol. 1993;10:87-97. doi:10.1111/j.1365-2958.1993.tb00906.x. PMID:7968522
   PubMed Web of Science ®Google Scholar
• Murphy TF , Kyd JM , John A , Kirkham C , Cripps AW . Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. J Infect Dis. 1998;178:1667-75. doi:10.1086/314501. PMID:9815219
   PubMed Web of Science ®Google Scholar
• Hsiao CB , Sethi S , Murphy TF . Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract. Microb Pathog. 1995;19:215-25. doi:10.1016/S0882-4010(95)90272-4. PMID:8825909
   PubMed Web of Science ®Google Scholar
• Murphy TF , Kirkham C , DeNardin E , Sethi S . Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis . Infect Immun. 1999;67:4578-85. PMID:10456903
   PubMed Web of Science ®Google Scholar
• Murphy TF , Kirkham C , Liu DF , Sethi S . Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease. Infect Immun. 2003;71:1288-94. doi:10.1128/IAI.71.3.1288-1294.2003. PMID:12595444
   PubMed Web of Science ®Google Scholar
• Murphy TF , Brauer AL , Yuskiw N , McNamara ER , Kirkham C . Conservation of outer membrane protein E among strains of Moraxella catarrhalis . Infect Immun. 2001;69:3576-80. doi:10.1128/IAI.69.6.3576-3580.2001. PMID:11349016
   PubMed Web of Science ®Google Scholar
• Murphy TF , Brauer AL , Yuskiw N , Hiltke TJ . Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants. Infect Immun. 2000;68:6250-6. doi:10.1128/IAI.68.11.6250-6256.2000. PMID:11035732
   PubMed Web of Science ®Google Scholar
• Adlowitz DG , Hiltke T , Lesse AJ , Murphy TF . Identification and characterization of outer membrane proteins G1a and G1b of Moraxella catarrhalis . Vaccine. 2004;22:2533-40. doi:10.1016/j.vaccine.2003.12.016. PMID:15193378
   PubMed Web of Science ®Google Scholar
• Adlowitz DG , Sethi S , Cullen P , Adler B , Murphy TF . Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis . Infect Immun. 2005;73:6601-7. doi:10.1128/IAI.73.10.6601-6607.2005. PMID:16177336
   PubMed Web of Science ®Google Scholar
• Adlowitz DG , Kirkham C , Sethi S , Murphy TF . Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease. FEMS Immunol Med Microbiol. 2006;46:139-46. doi:10.1111/j.1574-695X.2005.00020.x. PMID:16420607
   PubMedGoogle Scholar
• Yang M , Johnson A , Murphy TF . Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen. Infect Immun. 2011;79:846-57. doi:10.1128/IAI.00314-10. PMID:21134967
   PubMed Web of Science ®Google Scholar
• Jones MM , Johnson A . Role of the Oligopeptide Permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract. Infect Immun. 2014;82(11):4758-66. doi:10.1128/IAI.02185-14. PMID:25156736
   PubMed Web of Science ®Google Scholar
• Jones MM , Murphy TF . Expression of the oligopeptide permease operon of Moraxella catarrhalis is regulated by temperature and nutrient availability. Infect Immun. 2015;83(9):3497-505. doi:10.1128/IAI.00597-15. PMID:26099587
   PubMed Web of Science ®Google Scholar
• Luke-Marshall NR , Sauberan SL , Campagnari AA . Comparative analyses of the Moraxella catarrhalis type-IV pilus structural subunit PilA. Gene. 2011;477:19-23. doi:10.1016/j.gene.2011.01.010. PMID:21256201
   PubMed Web of Science ®Google Scholar
• Otsuka T , Kirkham C , Brauer A , Koszelak-Rosenblum M , Malkowski MG , Murphy TF . The vaccine candidate substrate binding protein SBP2 plays a key role in Arginine Uptake, which is required for growth of Moraxella catarrhalis . Infect Immun. 2015;84:432-8. doi:10.1128/IAI.00799-15. PMID:26597985
   PubMed Web of Science ®Google Scholar
• Otsuka T , Kirkham C , Johnson A , Jones MM , Murphy TF . Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis . Infect Immun. 2014;82:3503-12. doi:10.1128/IAI.01832-14. PMID:24914218
   PubMed Web of Science ®Google Scholar
• Myers LE , Yang YP , Du RP , Wang Q , Harkness RE , Schryvers AB , Klein MH , Loosmore SM . The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen. Infect Immun. 1998;66:4183-92. PMID:9712766
   PubMed Web of Science ®Google Scholar
• Chen D , McMichael JC , VanDerMeid KR , Masi AW , Bortell E , Caplan JD , Chakravarti DN , Barniak VL . Evaluation of a 74-kDa transferrin-binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate. Vaccine. 1999;18:109-18. doi:10.1016/S0264-410X(99)00188-7. PMID:10501241
   PubMed Web of Science ®Google Scholar
• Su YC , Hallstrom BM , Bernhard S , Singh B , Riesbeck K . Impact of sequence diversity in the Moraxella catarrhalis UspA2/UspA2H head domain on vitronectin binding and antigenic variation. Microbes Infect. 2013;15:375-87. doi:10.1016/j.micinf.2013.02.004. PMID:23474333
   PubMed Web of Science ®Google Scholar
• Chen D , Barniak V , VanDerMeid KR , McMichael JC . The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children. Infect Immun. 1999;67:1310-6. PMID:10024576
   PubMed Web of Science ®Google Scholar
• Mason KW , Zhu D , Scheuer CA , McMichael JC , Zlotnick GW , Green BA . Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Vaccine. 2004;22:3449-56. doi:10.1016/j.vaccine.2004.02.027. PMID:15308371
   PubMed Web of Science ®Google Scholar
• Mawas F , Ho MM , Huskisson R , Saydam M , Corbel MJ . Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis . Vaccine. 2007;25:4801-8. doi:10.1016/j.vaccine.2007.04.026. PMID:17507119
   PubMed Web of Science ®Google Scholar